Italy In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: April 30, 2020 Report Code: GDMEMC0515DB-ST

Select Item

GlobalData’s “Italy In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Italy In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health.

The Italy In Vitro Diagnostics Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for In Vitro Diagnostics Market.
• Global corporate-level profiles of key companies operating within the Italy In Vitro Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Italy In Vitro Diagnostics Tests is segmented as follows:

• Cardiac Disease

• Clinical Chemistry

• Hematological Disorders

• Hormonal Disorder

• Infectious Disease

• IVD Analyzers and Reagents

• Metabolic Disorder

• Oncology

• Women's Health

Reasons to Buy

Key Reasons to Purchase – The Italy In Vitro Diagnostics Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “Italy In Vitro Diagnostics Market Outlook to 2025” report:
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Abbott Laboratories

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 12

2.1 What Is This Report About? 12

2.2 In Vitro Diagnostics Market Segmentation 12

2.3 Definitions of Markets Covered in the Report 16

3 In Vitro Diagnostics Market, Italy 42

3.1 In Vitro Diagnostics Market, Italy, Revenue ($m), 2015-2025 42

3.2 In Vitro Diagnostics Market, Italy, Revenue Mix ($m), 2018 44

3.3 In Vitro Diagnostics Market, Italy, Category Contribution by Revenue ($m), 2018 45

3.4 In Vitro Diagnostics Market, Italy, Revenue ($m), 2015-2025 47

3.5 In Vitro Diagnostics Market, Italy, Volume (Units), 2015-2025 50

3.6 In Vitro Diagnostics Market, Italy, Volume (Units), 2015-2025 52

3.7 In Vitro Diagnostics Market, Italy, Company Share by Revenue ($m), 2018 55

4 Cardiac Disease Market, Italy 57

4.1 Cardiac Disease Market, Italy, Revenue ($m), 2015-2025 57

4.1.1 Cardiac Marker Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 59

4.2 Cardiac Disease Market, Italy, Volume (Units), 2015-2025 62

4.2.1 Cardiac Marker Tests Market, Italy, Volume (Units), by Segment, 2015-2025 64

4.3 Cardiac Disease Market, Italy, Average Price ($), 2015-2025 67

4.4 Cardiac Disease Market, Italy, Distribution Share by Revenue ($m), 2018 69

4.5 Cardiac Disease Market, Italy, Company Share by Revenue ($m), 2018 70

5 Clinical Chemistry Market, Italy 72

5.1 Clinical Chemistry Market, Italy, Revenue ($m), 2015-2025 72

5.1.1 Substrates Market, Italy, Revenue ($m), by Segment, 2015-2025 74

5.2 Clinical Chemistry Market, Italy, Volume (Units), 2015-2025 77

5.2.1 Substrates Market, Italy, Volume (Units), by Segment, 2015-2025 79

5.3 Clinical Chemistry Market, Italy, Average Price ($), 2015-2025 82

5.4 Clinical Chemistry Market, Italy, Distribution Share by Revenue ($m), 2018 84

5.5 Clinical Chemistry Market, Italy, Company Share by Revenue ($m), 2018 85

6 Hematological Disorders Market, Italy 86

6.1 Hematological Disorders Market, Italy, Revenue Mix ($m), 2018 86

6.2 Hematological Disorders Market, Italy, Segment Contribution (%), 2018 87

6.3 Hematological Disorders Market, Italy, Revenue ($m), 2015-2025 88

6.3.1 Hematology Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 90

6.3.2 Hemostasis Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 93

6.4 Hematological Disorders Market, Italy, Volume (Units), 2015-2025 96

6.4.1 Hematology Tests Market, Italy, Volume (Units), by Segment, 2015-2025 98

6.4.2 Hemostasis Tests Market, Italy, Volume (Units), by Segment, 2015-2025 101

6.5 Hematological Disorders Market, Italy, Average Price ($), 2015-2025 104

6.6 Hematological Disorders Market, Italy, Distribution Share by Revenue ($m), 2018 108

6.7 Hematological Disorders Market, Italy, Company Share by Revenue ($m), 2018 109

7 Hormonal Disorders Market, Italy 111

7.1 Hormonal Disorders Market, Italy, Revenue ($m), 2015-2025 111

7.1.1 Thyroid Function Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 113

7.2 Hormonal Disorders Market, Italy, Volume (Units), 2015-2025 116

7.2.1 Thyroid Function Tests Market, Italy, Volume (Units), by Segment, 2015-2025 118

7.3 Hormonal Disorders Market, Italy, Average Price ($), 2015-2025 121

7.4 Hormonal Disorders Market, Italy, Distribution Share by Revenue ($m), 2018 123

7.5 Hormonal Disorders Market, Italy, Company Share by Revenue ($m), 2018 124

8 Infectious Disease Market, Italy 126

8.1 Infectious Disease Market, Italy, Revenue Mix ($m), 2018 126

8.2 Infectious Disease Market, Italy, Segment Contribution (%), 2018 127

8.3 Infectious Disease Market, Italy, Revenue ($m), 2015-2025 129

8.3.1 Chlamydia Trachomatis Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 132

8.3.2 Clostridium difficile Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 134

8.3.3 Cytomegalovirus (CMV) Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 137

8.3.4 Hepatitis Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 139

8.3.5 Human Immunodeficiency Virus (HIV) Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 141

8.3.6 Human Papilloma Virus (HPV) Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 144

8.3.7 Human T-Lymphotropic Virus (HTLV) Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 146

8.3.8 Mycobacterium Tuberculosis Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 148

8.3.9 Neisseria Gonorrhoeae Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 150

8.3.10 Treponema pallidum Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 152

8.4 Infectious Disease Market, Italy, Volume (Units), 2015-2025 155

8.4.1 Chlamydia Trachomatis Tests Market, Italy, Volume (Units), by Segment, 2015-2025 160

8.4.2 Clostridium difficile Tests Market, Italy, Volume (Units), by Segment, 2015-2025 162

8.4.3 Cytomegalovirus (CMV) Tests Market, Italy, Volume (Units), by Segment, 2015-2025 165

8.4.4 Hepatitis Tests Market, Italy, Volume (Units), by Segment, 2015-2025 167

8.4.5 Human Immunodeficiency Virus (HIV) Tests Market, Italy, Volume (Units), by Segment, 2015-2025 169

8.4.6 Human Papilloma Virus (HPV) Tests Market, Italy, Volume (Units), by Segment, 2015-2025 172

8.4.7 Human T-Lymphotropic Virus (HTLV) Tests Market, Italy, Volume (Units), by Segment, 2015-2025 174

8.4.8 Mycobacterium Tuberculosis Tests Market, Italy, Volume (Units), by Segment, 2015-2025 176

8.4.9 Neisseria Gonorrhoeae Tests Market, Italy, Volume (Units), by Segment, 2015-2025 178

8.4.10 Treponema pallidum Tests Market, Italy, Volume (Units), by Segment, 2015-2025 180

8.5 Infectious Disease Market, Italy, Average Price ($), 2015-2025 183

8.6 Infectious Disease Market, Italy, Distribution Share by Revenue ($m), 2018 189

8.7 Infectious Disease Market, Italy, Company Share by Revenue ($m), 2018 190

9 IVD Analyzers and Reagents Market, Italy 192

9.1 IVD Analyzers and Reagents Market, Italy, Revenue Mix ($m), 2018 192

9.2 IVD Analyzers and Reagents Market, Italy, Segment Contribution (%), 2018 193

9.3 IVD Analyzers and Reagents Market, Italy, Revenue ($m), 2015-2025 194

9.3.1 Clinical Chemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2015-2025 197

9.3.2 Hematology Analyzers Market, Italy, Revenue ($m), by Segment, 2015-2025 199

9.3.3 Immunochemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2015-2025 202

9.3.4 Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), by Segment, 2015-2025 205

9.4 IVD Analyzers and Reagents Market, Italy, Volume (Units), 2015-2025 208

9.4.1 Clinical Chemistry Analyzers Market, Italy, Volume (Units), by Segment, 2015-2025 211

9.4.2 Hematology Analyzers Market, Italy, Volume (Units), by Segment, 2015-2025 213

9.4.3 Immunochemistry Analyzers Market, Italy, Volume (Units), by Segment, 2015-2025 216

9.4.4 Polymerase Chain Reaction (PCR) Systems Market, Italy, Volume (Units), by Segment, 2015-2025 219

9.5 IVD Analyzers and Reagents Market, Italy, Average Price ($), 2015-2025 222

9.6 IVD Analyzers and Reagents Market, Italy, Distribution Share by Revenue ($m), 2018 226

9.7 IVD Analyzers and Reagents Market, Italy, Company Share by Revenue ($m), 2018 227

10 Metabolic Disorder Market, Italy 229

10.1 Metabolic Disorder Market, Italy, Revenue ($m), 2015-2025 229

10.1.1 Diabetes Assays Market, Italy, Revenue ($m), by Segment, 2015-2025 231

10.2 Metabolic Disorder Market, Italy, Volume (Units), 2015-2025 234

10.2.1 Diabetes Assays Market, Italy, Volume (Units), by Segment, 2015-2025 236

10.3 Metabolic Disorder Market, Italy, Average Price ($), 2015-2025 239

10.4 Metabolic Disorder Market, Italy, Distribution Share by Revenue ($m), 2018 241

10.5 Metabolic Disorder Market, Italy, Company Share by Revenue ($m), 2018 242

11 Oncology Market, Italy 244

11.1 Oncology Market, Italy, Revenue Mix ($m), 2018 244

11.2 Oncology Market, Italy, Segment Contribution (%), 2018 245

11.3 Oncology Market, Italy, Revenue ($m), 2015-2025 247

11.3.1 ALK Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 250

11.3.2 BRCA Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 252

11.3.3 Colorectal Cancer Screening Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 254

11.3.4 EGFR Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 256

11.3.5 HER2 Amplification Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 259

11.3.6 KRAS Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 261

11.4 Oncology Market, Italy, Volume (Units), 2015-2025 263

11.4.1 ALK Tests Market, Italy, Volume (Units), by Segment, 2015-2025 266

11.4.2 BRCA Tests Market, Italy, Volume (Units), by Segment, 2015-2025 268

11.4.3 Colorectal Cancer Screening Tests Market, Italy, Volume (Units), by Segment, 2015-2025 270

11.4.4 EGFR Tests Market, Italy, Volume (Units), by Segment, 2015-2025 272

11.4.5 HER2 Amplification Tests Market, Italy, Volume (Units), by Segment, 2015-2025 275

11.4.6 KRAS Tests Market, Italy, Volume (Units), by Segment, 2015-2025 277

11.5 Oncology Market, Italy, Average Price ($), 2015-2025 279

11.6 Oncology Market, Italy, Distribution Share by Revenue ($m), 2018 283

11.7 Oncology Market, Italy, Company Share by Revenue ($m), 2018 284

12 Women's Health Market, Italy 286

12.1 Women's Health Market, Italy, Revenue Mix ($m), 2018 286

12.2 Women's Health Market, Italy, Segment Contribution (%), 2018 287

12.3 Women's Health Market, Italy, Revenue ($m), 2015-2025 288

12.3.1 Prenatal Screening Market, Italy, Revenue ($m), by Segment, 2015-2025 290

12.3.2 Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 293

12.4 Women's Health Market, Italy, Volume (Units), 2015-2025 296

12.4.1 Prenatal Screening Market, Italy, Volume (Units), by Segment, 2015-2025 298

12.4.2 Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), by Segment, 2015-2025 301

12.5 Women's Health Market, Italy, Average Price ($), 2015-2025 304

12.6 Women's Health Market, Italy, Distribution Share by Revenue ($m), 2018 308

12.7 Women's Health Market, Italy, Company Share by Revenue ($m), 2018 309

13 Overview of Key Companies in Italy, In Vitro Diagnostics Market 311

13.1 F. Hoffmann-La Roche Ltd 311

13.1.1 Company Overview 311

13.2 Siemens Healthineers AG 311

13.2.1 Company Overview 311

13.3 Abbott Laboratories 311

13.3.1 Company Overview 311

13.4 Danaher Corp 312

13.4.1 Company Overview 312

13.5 Sysmex Corp 312

13.5.1 Company Overview 312

13.6 Ortho-Clinical Diagnostics Inc 312

13.6.1 Company Overview 312

13.7 Qiagen NV 312

13.7.1 Company Overview 312

13.8 Beckman Coulter Inc 313

13.8.1 Company Overview 313

13.9 Bio-Rad Laboratories Inc 313

13.9.1 Company Overview 313

13.10 Horiba Ltd 313

13.10.1 Company Overview 313

13.11 Hologic Inc 314

13.11.1 Company Overview 314

13.12 bioMerieux SA 314

13.12.1 Company Overview 314

14 In Vitro Diagnostics Market Pipeline Products 315

15 Financial Deals Landscape 319

15.1 Acquisition 319

15.1.1 Lifebrain Acquires Galeno 319

15.1.2 Impact Lab Acquires Toma Advanced Biomedical Assays 320

15.2 Partnerships 321

15.2.1 Fujirebio Europe Enters into Distribution Agreement with Atila Biosystems 321

15.2.2 QuantuMDx and SpeeDx Enter into Agreement with Foundation for Innovative New Diagnostics (FIND) 322

15.2.3 Pillar Biosciences Enters into Co-Marketing Agreement with MGI Tech 323

15.2.4 Dongsung Pharma Enters into Licensing Agreement with Korea Electrotechnology Research Institute 324

15.2.5 Qiagen and DiaSorin Enter into Development Collaboration 325

15.3 Private Equity 326

15.3.1 ArchiMed Acquires Diesse Diagnostica Senese 326

16 Recent Developments 328

16.1 Corporate Communications 328

16.1.1 Sep 12, 2019: Menarini: Elcin Barker Ergun Group CEO 328

16.1.2 Aug 20, 2019: PredictImmune appoints Tim Rea of BGF as non-executive director 328

16.1.3 Jun 19, 2019: Salvatore Butti to become General Manager Italy at STADA Group 329

16.2 Financial Announcements 329

16.2.1 Nov 21, 2019: Bio-Path Holdings announces clearance of Investigational New Drug application for BP1002 329

16.2.2 Jul 17, 2019: Abbott reports second-quarter 2019 results 330

16.2.3 Apr 25, 2019: Biocartis Group Q1 2019 Business Update 332

16.2.4 Apr 24, 2019: Thermo Fisher Scientific announces first quarter 2019 results 335

16.2.5 Mar 21, 2019: IBA reports full year 2018 results 336

16.3 Legal And Regulatory 338

16.3.1 Apr 26, 2019: COPAN Italia announces the filing of a lawsuit against Svenska Laboratorieförsäljningen Aktiebolag, LABFAB, in the Swedish Patent and Market Court, for infringement of European Patent EP 1 608 268 B2 338

16.4 Other Significant Developments 338

16.4.1 May 08, 2019: Pacific Urology to Conduct Overactive Bladder Clinical Feasibility Study 338

16.4.2 Apr 17, 2019: Medibio announces sponsored research agreement with Humanitas University 339

16.4.3 Apr 08, 2019: PHI expands European distributor network 340

16.5 Product News 340

16.5.1 Sep 30, 2019: Blood test may replace biopsy in advanced lung cancer 340

16.5.2 Jun 18, 2019: Menarini Silicon Biosystems introduces use of DEPArray System for challenging flow cytometry applications at CYTO Congress 340

16.5.3 Apr 28, 2019: Single dose of targeted radiotherapy is safe and effective for prostate cancer 341

16.6 Strategy And Business Planning 342

16.6.1 Nov 13, 2019: Thermo Fisher Scientific announces membership of the Pistoia Alliance 342

16.6.2 Jun 07, 2019: Qiagen and DiaSorin to develop test for Lyme disease 342

17 Appendix 344

17.1 Research Methodology 345

17.1.1 Coverage 345

17.1.2 Secondary Research 345

17.1.3 Primary Research 346

17.1.4 Market Modeling and Forecasting 347

17.1.5 Company Share Analysis 348

17.1.6 Distribution Share Analysis 349

17.1.7 Benchmarking 349

17.2 GlobalData Consulting 349

17.3 Contact Us 350

17.4 Disclaimer 350

Frequently asked questions

Italy In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. thematic reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
India Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | June 2020
Medical Devices
Japan Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | June 2020
Medical Devices
New Zealand Surgical Energy Instruments Market Size (Value, Volume, ASP)…
$500 | June 2020
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Italy In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. in real time.

  • Access a live Italy In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more